These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28242139)

  • 1. Models for the risk of secondary cancers from radiation therapy.
    Dasu A; Toma-Dasu I
    Phys Med; 2017 Oct; 42():232-238. PubMed ID: 28242139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Special radiobiological features of second cancer risk after particle radiotherapy.
    Trott KR
    Phys Med; 2017 Oct; 42():221-227. PubMed ID: 29103987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of secondary cancers: Bridging epidemiology and modeling.
    Schneider U; Walsh L
    Phys Med; 2017 Oct; 42():228-231. PubMed ID: 28363341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2-dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer.
    Joosten A; Bochud F; Moeckli R
    Phys Med Biol; 2014 Aug; 59(16):4697-722. PubMed ID: 25082795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk?
    Bostrom PJ; Soloway MS
    Eur Urol; 2007 Oct; 52(4):973-82. PubMed ID: 17644245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of risk estimation models for the induction of secondary cancers following radiotherapy.
    Daşu A; Toma-Daşu I; Olofsson J; Karlsson M
    Acta Oncol; 2005; 44(4):339-47. PubMed ID: 16120542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age at exposure and attained age variations of cancer risk in the Japanese A-bomb and radiotherapy cohorts.
    Schneider U; Walsh L
    Med Phys; 2015 Aug; 42(8):4755-61. PubMed ID: 26233203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IMRT combined to IGRT: increase of the irradiated volume. Consequences?].
    Lisbona A; Averbeck D; Supiot S; Delpon G; Ali D; Vinas F; Diana C; Murariu C; Lagrange JL
    Cancer Radiother; 2010 Oct; 14(6-7):563-70. PubMed ID: 20729117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric risk estimates of radiation-induced malignancies after intensity modulated radiotherapy.
    Patil VM; Kapoor R; Chakraborty S; Ghoshal S; Oinam AS; Sharma SC
    J Cancer Res Ther; 2010; 6(4):442-7. PubMed ID: 21358077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review.
    Tubiana M
    Radiother Oncol; 2009 Apr; 91(1):4-15; discussion 1-3. PubMed ID: 19201045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of IMRT and proton radiotherapy on secondary cancer incidence.
    Schneider U; Lomax A; Pemler P; Besserer J; Ross D; Lombriser N; Kaser-Hotz B
    Strahlenther Onkol; 2006 Nov; 182(11):647-52. PubMed ID: 17072522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second cancer after radiotherapy, 1981-2007.
    Bartkowiak D; Humble N; Suhr P; Hagg J; Mair K; Polivka B; Schneider U; Bottke D; Wiegel T
    Radiother Oncol; 2012 Oct; 105(1):122-6. PubMed ID: 21993405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers.
    Chuang SC; Hashibe M; Yu GP; Le AD; Cao W; Hurwitz EL; Rao JY; Neugut AI; Zhang ZF
    Cancer Lett; 2006 Jul; 238(1):42-52. PubMed ID: 16039041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk of postirradiation induction of cancer of the modern methods of radiotherapy (3D CRT and IMRT) head and neck cancer].
    Milecki P; Szyfter K; Skowronek J
    Otolaryngol Pol; 2004; 58(5):887-93. PubMed ID: 15732771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated risk for secondary cancer in the contra-lateral breast following radiation therapy of breast cancer.
    Johansen S; Danielsen T; Olsen DR
    Acta Oncol; 2008; 47(3):391-6. PubMed ID: 18348001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy.
    Bezak E; Takam R; Yeoh E; Marcu LG
    Phys Med; 2017 Oct; 42():253-258. PubMed ID: 28302493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiobiologic comparison of helical tomotherapy, intensity modulated radiotherapy, and conformal radiotherapy in treating lung cancer accounting for secondary malignancy risks.
    Komisopoulos G; Mavroidis P; Rodriguez S; Stathakis S; Papanikolaou N; Nikiforidis GC; Sakellaropoulos GC
    Med Dosim; 2014; 39(4):337-47. PubMed ID: 25168596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left-sided breast cancer and risks of secondary lung cancer and ischemic heart disease : Effects of modern radiotherapy techniques.
    Corradini S; Ballhausen H; Weingandt H; Freislederer P; Schönecker S; Niyazi M; Simonetto C; Eidemüller M; Ganswindt U; Belka C
    Strahlenther Onkol; 2018 Mar; 194(3):196-205. PubMed ID: 28916844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second cancers after fractionated radiotherapy: stochastic population dynamics effects.
    Sachs RK; Shuryak I; Brenner D; Fakir H; Hlatky L; Hahnfeldt P
    J Theor Biol; 2007 Dec; 249(3):518-31. PubMed ID: 17897680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.